Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (351-360 of 565) with videos related to

Pageof 57
Sort By:
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 2, 2021
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in BrazilJosé R Jardim, Francisco Casas-Maldonado, Frederico Leon Arrabal Fernandes, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 16, 2022
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance TherapyStephanie Chen, Marc Miravitlles, Chin Kook Rhee, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 4, 2023
Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi ConsensusMarc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2018
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC studyAlejandro Casas, Maria Montes de Oca, Ana Mb Menezes, et al.
NPJ Primary Care Respiratory Medicine|June 21, 2017
Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world studyKevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, et al.
NPJ Primary Care Respiratory Medicine|March 31, 2017
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observationalKevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, et al.
Lung|September 23, 2018
Ischiocrural Strength May Be a Better Prognostic Marker Than Quadriceps Strength in COPDEulogio Pleguezuelos, Lluis Guirao, Eva Moreno, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 28, 2017
Palliative care and prognosis in COPD: a systematic review with a validation cohortPere Almagro, Sergi Yun, Ana Sangil, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 21, 2022
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled CorticosteroidMarc Miravitlles, Katia Verhamme, Peter M A Calverley, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2026
Real-Life Effectiveness of Aclidinium/Formoterol on COPD Control: The REDACT Observational StudyKonstantinos Kostikas, Stylianos Loukides, Nikolaos Tzanakis, et al.
Pageof 57

Showing results (351-360 of 565) with videos related to

Sort By:
Pageof 57
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 2, 2021
Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in BrazilJosé R Jardim, Francisco Casas-Maldonado, Frederico Leon Arrabal Fernandes, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 16, 2022
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance TherapyStephanie Chen, Marc Miravitlles, Chin Kook Rhee, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 4, 2023
Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi ConsensusMarc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2018
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC studyAlejandro Casas, Maria Montes de Oca, Ana Mb Menezes, et al.
NPJ Primary Care Respiratory Medicine|June 21, 2017
Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world studyKevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, et al.
NPJ Primary Care Respiratory Medicine|March 31, 2017
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observationalKevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, et al.
Lung|September 23, 2018
Ischiocrural Strength May Be a Better Prognostic Marker Than Quadriceps Strength in COPDEulogio Pleguezuelos, Lluis Guirao, Eva Moreno, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 28, 2017
Palliative care and prognosis in COPD: a systematic review with a validation cohortPere Almagro, Sergi Yun, Ana Sangil, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 21, 2022
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled CorticosteroidMarc Miravitlles, Katia Verhamme, Peter M A Calverley, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2026
Real-Life Effectiveness of Aclidinium/Formoterol on COPD Control: The REDACT Observational StudyKonstantinos Kostikas, Stylianos Loukides, Nikolaos Tzanakis, et al.
Pageof 57